Details for 2021158979
Up to date per 27.04.2026
Actions
Details for 2021158979
Deleted
European Patent
30.06.2021 A
09.03.2022 B1
11.01.2016
US
201662277232 P
13.07.2016
US
201662361605 P
A61K 31/167 20060101AFI20210514BHEP
Owner
Egetis Therapeutics ABKlara Norra Kyrkogata 26 111 22 StockholmSE
Representative
No representatives present
Inventor
NÄSSTRÖM, JacquesSkällnoravägen 6 168 39 BrommaSE
JACOBSSON, Svenc/o Jacobsson Sankt Eriksplan 7, 2tr 113 20 StockholmSE
HENRIKSEN, DennisHvidehusvej 13 3450 AllerødDK
VAN ALSTINE, JamesOrvar Odds väg 8 112 54 StockholmSE